NDC 0024-5919 – Dupixent
Dupilumab 200 mg/1.14mL · Injection, Solution · Subcutaneous
Product NDC0024-5919
Product details
- Brand name
- Dupixent
- Generic name
- Dupilumab
- Labeler
- Sanofi-Aventis U.S. LLC
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761055
- Marketed since
- June 14, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-4 Receptor alpha Antagonist
Active ingredients
- Dupilumab 200 mg/1.14mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0024-5919-02 | 2 SYRINGE, GLASS in 1 CARTON (0024-5919-02) / 1.14 mL in 1 SYRINGE, GLASS (0024-5919-00) | Jun 14, 2021 |
| 0024-5919-20 | 2 SYRINGE, GLASS in 1 CARTON (0024-5919-20) / 1.14 mL in 1 SYRINGE, GLASS (0024-5919-01) | Jun 14, 2021 |